Skip to main content

Announcing the 2024 Global Board of Directors

2024 Board of Directors

At today’s Healthcare Businesswomen's Association’s (HBA) Annual Business Meeting, the membership electorate voted on the board leadership that will ensure the organizational focus, strategies, and plans are aligned to accelerate HBA’s mission and support our vision. 

We are proud to announce the 2024 HBA Global Board of Directors: 

  • Chair: Carol Montandon | Global Chief Quality Officer and Worldwide VP, Quality and Compliance, Johnson & Johnson 
  • Vice Chair: Tamika Jean-Baptiste | VP and Chief Diversity Officer, Amgen Inc. 
  • Secretary/Treasurer: Marie-Caroline Chauvet | Partner - France, Insigniam  
  • HBA CEO (ex-officio, non-voting): Mary Stutts 

Directors At Large 

  • Tanya Alcorn | SVP, Sterile Injectables and Biotech Operations, Pfizer Inc. 
  • Wendy Short Bartie | SVP, US Hematology, Bristol Myers Squibb  
  • Paula Bekinschtein | Founder and Managing Director, WalkBek Consulting 
  • Adam Dubow | General Counsel, Day One Biopharmaceuticals  
  • Sandra Forero | COO, ZS  
  • Deborah Gordon | EVP and Chief Administrative and Legal Officer, Memorial Hermann Health System 
  • Nicola Greenway | SVP, Group Head of HR, Global Portfolio Division, Takeda Pharmaceuticals, Inc. 
  • Sabine Hutchison | CEO, Seuss+ (HBA EMEA Operating Board President) 
  • Nyawira Njeru | Director Market Access and Strategic Partnerships - Middle East and Africa, Hologic, Inc. 
  • Miguel Serrano Kieckebusch | CFO, Compremium AG 
  • Karima Sharif | Managing Director, Initiative (HBA North America Operating Board President) 
  • Victoria Williams | SVP and General Manager, GSK 

The generous donation of time, talent, and expertise from Board members enables the HBA to sustain and evolve our business strategies while maintaining a laser focus on the longer-term goal of gender equity at all levels of leadership around the globe. 

We are also happy to announce the 2024 HBA Nominating Committee: 

  • Chair: Julie Ross, President and CEO, Advanced Clinical (appointed by the Board) 
  • Jocelyn Allen | Head, One Finance Experience, Sanofi  
  • Andrea Loewendorf | Global Head Market Access Strategy and Pricing, UCB, Inc. 
  • Erik D. Smith, PhD | Principal, Strategy and Analytics, Life Sciences, Deloitte LLP 
  • Kristen Von Seggern, PhD | VP, Strategic Programs, Johnson & Johnson 

As the new Board and Nominating Committee prepare for the year ahead, we also want to graciously thank the 2023 Global Board of Directors. 

A special thank you to members completing their term of Board service: 

  • Gisela Paulsen, Chief Operating Officer, Harbinger Health 
  • Dianne Yurek, Advisor, Healthcare Strategy & Innovation